04/10/2015 04:12:01 Cookie Policy Free Membership Login

Aortech Intl Share Chat - AOR

Share Name Share Symbol Market Type Share ISIN Share Description
Aortech International LSE:AOR London Ordinary Share GB0033360586 ORD 5P
  Price Change Price Change % Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00 +0.00% 38.00 36.00 40.00 38.00 38.00 38.00 0 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.8 -0.3 -7.7 - 1.84

Aortech Share Discussion Threads

Showing 3251 to 3273 of 3275 messages
Post New Message
Chat Pages: 131  130  129  128  127  126  125  124  123  122  121  120  >>
Hi Gents - thanks for the notes - I am perhaps always as a long standing shareholder ( 1999) just too beaten up to believe all that yet - Hope you are right/ Thanksharrogate
Harrogate As a fellow shareholder of longstanding (some may say long suffering)I understand your caution I am not noted for wild bouts of optimism particularly with Aor however I do recognise a fundamental shift both in sentiment and in what has been achieved over the last 12 months. I feel we are at an inflexion point for the share price which as we all know tends to anticipate events well in advance 12 month results pointed to a profitable stable company now crucially happy with its renegotiated relationship with Biomerics, confident in a ring fenced litigation process and now fully focused in releasing shareholder value through expanding its licencees and at long last attempting to realise the massive opportunity offered by its heart valve( backed by extensive patent protection). Let us wait for the evidence but the signs are already there. Once the evidence is out there the share price will imo be north of £1 and an opportunity missed. The tiny £2m current market cap imo offers a risk/reward ratio substantially in favour of the investor. That value is what I am trying to highlight.It would seem I am not alone Let us hope I am right Regards SPspurious
Harrogate You are correct that there would appear to be masses of work to do, but reading the last statement would suggest that the outcome of that work should be positive. The IP position is better than 1999, there are 3 generations of patent filings since then some very recent. The key to value would seem to be can they identify a credible team to take the project forward?landy90
On Tip TV today.. After the crash Zak identifies the top 10 shares to buy TODAY for the autumn in his new book published 1st September. Get your free copy HERE Aortech International (AOR): 70p Price Channel Destination It has not exactly been a pleasant ride in terms of the daily chart progression over the past couple of years. This is a point witnessed by the decline seen from 130p plus in the autumn of 2013, to a probe below 20p in March. Since then there has been a rehabilitation process, one which has involved higher support points since the spring above 20p, and hen the recovery of the 50 day and 200 day moving averages both currently at 28p. The implication now in the wake of this extended base building is that the bulls should be happy to enjoy the latest golden cross buy signal between the 50 day and 200 day moving averages, with the message being that provided there is no end of day close back below these lines we should be wedded to the buy argument. Just how high the stock could fly over the next 1-2 months is suggested by the top of a rising trend channel, one which has been in place from as long ago as June last year. The best way forward on this basis would be to buy into Aortech International shares on any initial weakness which cools off the overbought RSI, now at 83. - See more at: http://www.shareprophets.com/views/14986/zak-mir-s-great-request-show-aortech-international-ncondezi-energy-petro-matad#sthash.uEAhVqWw.dpufgac141
It is great that we no longer seem to be at death's door but we should also not get carried away. The £3 share price of 3 years ago was really down to the value we felt we added to St Jude on the leads which turned out to be a complete illusion. My reading of the last RNS was that in terms of any real data on the heart valve we are back to 1999 almost and that there is a massive amount of work to do and won't any IP protection have lapsed by now? I also have not seen any evidence as you say above that " we are rapidly building turnover" there has been little evidence of new licenses of our technology. I am a lot more confident than I was 12 months ago but lots to do. Let's hope the management team are up to it - the are clearly good at fire fighting but that is a different kettle of fish.harrogate
Hi George Whether we get an update on progress at the agm or whether that comes some weeks later I am confident we will get news confirming we are in an exciting new chapter built on solid profitable foundations As you point out people forget that the heart valve did represent a £32 million opportunity and if sold on to a major player after successful in house testing/validation/regulatory approval then this figure could easily double So for a relatively modest outlay (borne by its partner) Aor could be sitting on a gold mine. A JV may be the best way to unlock the potential and ring fence costs while offering a share in future profits As Aor pointed out recently much of the testing has already been successfully carried out for the heart valve and it shows potential to be a world beater particularly due to the very significant cost savings over its rivals Aor highlighted the opportunity at results when it announced it was exploring ways of bringing a team together to develop the value Aor is now profitable and rapidly building turnover and profits from a stable/falling cost base Aor as a loss making Co enjoyed a share price in excess of £3 a couple of years ago and while I agree the share price is only a barometer of sentiment and expectation some of that optimism is now being realised in terms of real profits and opportunity The heart valve is in the share price for free so is the potential £1 mil outcome of the ongoing litigation against Mcguire We have a £2m market cap without the risk and negativity of previous years where we enjoyed a cap in excess of £10m as a loss maker with nil turnover Incredible ! Value will out Great time to be an Aor shareholder imo Best wishes SPspurious
I hope you are right.. P I think we may have to be more patient... although any good news could move things very quickly. The building blocks have been put in place.gac141
Have to echo your sentiments George. I am hoping the agm this month may provide the ideal opportunity for some positive news. Just as the downside on the share price was greatly exaggerated, the corresponding effect on any positive news will be an equally swift and strong rise I am confident we will see a share price well in excess of £1 in a matter of weeks. Value will outspurious
Well said gac141.tadders2
Aortech are clearly very much on their feet again and the prospect of insolvency has virtually disappeared. The market cap on this company is ridiculous bearing in mind what they have to offer. Elasteon and its other derivatives are amongst the best products for in body use anywhere in the world. We also have the heart valve which at one point st Jude medical were going to pay 32 million for. Again I congratulate Roy and Eddie for the tireless work they have put in to saving the company from the clutches of despicable businesses and people who were corrupt to the core. I once again look forward to Aortech being a valued company and an excellent asset to my portfolio. Good times ahead.......?gac141
Hi Paul I regret selling Ind way too early, albeit at a good profit and well done for being so patient Biomerics relationship is key and for the first time this appears to be working. I am very hopeful we will see the benefits of this shortly in new increased repeat orders for Elasteon. Throw in a possible JV on the heart valve and a company confident in successfully pursuing a million dollar claim and you certainly have the makings of a multi-bagger. Aor enjoyed a share price in excess of £3 in last couple of years while loss making. It is now making profit. I am confident the share price will soon respond Best regards Patrickspurious
Hi Patrick, I'm still in IND - 11 years now lol! This is a nice little summary of Aortech, from its most recent results statement: "Despite the time and commitment required in the litigation action, the past year has been one of relative success. Revenue from license fees and royalties are now greater than overheads, the Company was cash positive in the second half of the year, progress is being made with our key licensees and we expect the year 2015/16 to be one of further progress." Not bad for a mkt cap of only about £1.6m. PP.paulypilot
AOR next bagger? £1.5mil mcap 5million shares in issue Broken 200MA Financial summary · Group revenue from continuing operations doubled from previous year to US$844k · Operating profit of US$81k (2014: US$440k loss) before amortisation costs and exceptional items · Loss from continuing operations more than halved from US$823k to US$326kileeman
Hi Paul Nice to see a familiar face from old times (indigo Vis days ) Look forward to your input Genuinely think your timing is perfect, as usual, and looking forward to some positive news in near future Roy has laid a great foundation Regards Patrickspurious
Hi gac141, I agree. Roy is a good egg, and he seems to have been instrumental in turning things around, to give the company a fighting chance of a resurgence. The most recent results gave me the impression that there's no likelihood of this company going bust now, and indeed the outlook comments sounded pretty positive. The market cap is absolute peanuts, so some good news could see this multi-bag. For that reason I bought some stock on & after results day. Bit of a punt, but it looks potentially interesting I think. Regards, Paul.paulypilot
Looking back at the results and the progress made.. I think that the foundation with Biomerics seems finally to be working and with this much more stable background we may see people being attracted to our products. It is a hope but the huge efforts put in by Roy and Eddie over the last year or so have saved the company and may have given it the chance to reward shareholders going forward.gac141
Somebody buying as well.tadders2
Griffiths dumpingmikeh30
Good set of results.cortana1
It is all on the blog bbr391bbr391
spot on harrogate. Same cash cow , just different director milking itcocker
www.proactiveinvestors.co.uk/companies/news/109772/aortech-doubles-sales-halves-losses-109772.htmlmister md
Great effort by Roy and Eddie to put us in position to maximise potential for long suffering shareholdersspurious
Chat Pages: 131  130  129  128  127  126  125  124  123  122  121  120  >>

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 151004 04:12